This study examined the prevalence of drug allergy labels (DALs) among pediatric patients with inborn errors of immunity (IEI), a population with high antimicrobial exposure and complex medication needs.
The paper metadata provided contains no abstract or results section, so specific prevalence rates, sample size, and outcome data cannot be extracted.
Pediatric IEI patients are at elevated risk of accumulating drug allergy labels due to frequent antimicrobial use; clinicians should proactively review and de-label inaccurate DALs in this population to avoid therapeutic restrictions.
Explore related topics
